New Current Report Filed with the SEC Disclosing Occurrence of a Material Impairment: 8-K – Eleven Biotherapeutics, Inc. (0001485003) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of a material impairment. Details of the current report are:

8-K – Eleven Biotherapeutics, Inc. (0001485003) (Filer)
Filed: 2016-06-22 AccNo: 0001485003-16-000116 Size: 34 KB

Item 2.05: Cost Associated with Exit or Disposal Activities

Item 2.06: Material Impairments
Filing Date: 2016-06-22T16:26:48-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: